Receptor-activated transcription factors and beyond: multiple modes of Smad2/3-dependent transmission of TGF-β signaling
Open Access
- 2 April 2024
- journal article
- review article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107256
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (19KK0400, 20H00513, 23H05486, 21H02762)
This publication has 381 references indexed in Scilit:
- Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatmentMolecular Oncology, 2021
- Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation siteBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Opposing Roles for Smad2 and Smad3 in Peritoneal Fibrosis in Vivo and in VitroThe American Journal of Pathology, 2014
- Regulation of Renal Fibrosis by Smad3 Thr388 PhosphorylationThe American Journal of Pathology, 2014
- Homo- and Heterodimerization in Transcriptional Regulation2012
- Diverse roles of TGF‐β receptor II in renal fibrosis and inflammation in vivo and in vitroThe Journal of Pathology, 2011
- Identification of novel Smad2 and Smad3 associated proteins in response to TGF‐β1Journal of Cellular Biochemistry, 2008
- A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF‐β signalingJournal of Cellular Biochemistry, 2007
- Functional interaction between Smad, CREB binding protein, and p68 RNA helicaseBiochemical and Biophysical Research Communications, 2004
- TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequenceCell, 1990